Marval advised Diagnosticos da America SA, one of the largest healthcare groups in the world and a leader in diagnostic medicine in Brazil and Latin America, on the sale of 100% of the share capital of Diagostico Maipu to Swiss Medical, a leading company in the Argentine healthcare market.
Diagnostico Maipu is a key player in the local healthcare ecosystem, operating as a diagnostic imaging center for low, medium, and high complexity studies, as well as a clinical analysis laboratory, with 30 care centers and over 1,600 direct employees, including administrative staff, technicians, biochemists, and physicians.
The transaction—executed within a compressed timeline of just over two weeks—involved:
- acquiring minority shareholdings,
- executing settlement agreements to terminate various outstanding call option agreements,
- simultaneously signing and closing agreements in Argentina and Brazil.
DASA’s team was led by Andre Covre, Paula Ligia Oliveira Dias, and Renata Rodrigues Bruno Borba. BTG Pactual also advised DASA, through Rafael Ibarra and team.
Marval’s team was led by partners Pablo A. Artagaveytia and Maria Macarena Garcia Mirri, together with associates Lucía D. Trillo, Agustin H. Queirolo, Maria Victoria Guerricagoitia, and Jazmin Sofia Rodriguez.
Swiss Medical was advised by Croz Tax & Legal, led by partner Hernan Carassai, together with associates Maria Belen Decaro, Juan Pablo Nieto, Nuria Borda, Pablo Rios, and Raul Mazzarello.